Skip to main content

Bicara Therapeutics

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical enterprise headquartered in Boston, Massachusetts. The company focuses on the discovery and development of dual-action antibody therapeutics designed to treat complex oncological conditions and solid tumors. Its proprietary pipeline features targeted immunotherapy candidates that combine tumor-targeting antibodies with immune-activating agents to enhance patient treatment response. Principal revenue is currently earned through private financing, research grants, and clinical development collaborations. Bicara Therapeutics Inc is publicly traded on the Nasdaq Stock Market.

6 of the funds FundTelligence covers report a position in Bicara Therapeutics.

Legal name
Bicara Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
6

Funds holding Bicara Therapeutics

Loading...